Skip to main content
Premium Trial:

Request an Annual Quote

Arcadia Biosciences Licenses Broad Institute CRISPR IP

NEW YORK (GenomeWeb) – Ag-bio firm Arcadia Biosciences announced today that has it acquired a worldwide, nonexclusive license to the Broad Institute's intellectual property on CRISPR-Cas9 genome-editing technology.

According to Arcadia, the research-use license allows it to use the patented technology to develop nutritional and agricultural productivity traits in its core crops. Additional terms of the deal were not disclosed.

"CRISPR-Cas9 is a high-throughput, cost-effective development tool that is complementary to our ongoing Tilling [advanced breeding technology] and transgenic development platforms," Arcadia President and CEO Raj Ketkar said in a statement. "We expect this technology will significantly improve the time to market for a number of our innovative traits addressing large-acre, high-value crops."

The Scan

Foxtail Millet Pangenome, Graph-Based Reference Genome

Researchers in Nature Genetics described their generation of a foxtail millet pangenome, which they say can help in crop trait improvement.

Protein Length Distribution Consistent Across Species

An analysis in Genome Biology compares the lengths of proteins across more than 2,300 species, finding similar length distributions.

Novel Genetic Loci Linked to Insulin Resistance in New Study

A team reports in Nature Genetics that it used glucose challenge test data to home in on candidate genes involved in GLUT4 expression or trafficking.

RNA Editing in Octopuses Seems to Help Acclimation to Shifts in Water Temperature

A paper in Cell reports that octopuses use RNA editing to help them adjust to different water temperatures.